KADCYLA Reviews (ADO-TRASTUZUMAB EMTANSINE)Average Rating: 4.3 (6 Ratings)Filter ResultsCompare KADCYLA with similar:
Type: Biological Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
| RATING | REASON | SIDE EFFECTS FOR KADCYLA | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
| 4 | Breast cancer | Stomach pain, bladder infections, fatigue, problems sleeping, bleeding gums, runny nose, dry eyes, headaches, constipation, swelling, weight gain, anxiousness, digestive issues, muscle pain, joint pain, itchiness, under arm needle like pain, brittle nails, exercise fatigue, low grade fever | Kadcyla, as with all chemos is hard, but compared to the combination of docetaxel, carboplantin, herception, and perjta, it is a lot easier to endure. My dosage was immediately reduced from 200mg to 160mg after first dose because The side effects were too intense for me. The side effects are intense at first and then after 4 day increments it becomes easier. As each dose is given it is taking a little longer to start feeling better. Although my liver enzymes are in normal range they are creeping up to the high side of normal by 10 dose. | F | 58 | 42 weeks 160mg 1X O | 4/1/2022 | 5 | Metastatic breast cancer | Little tired. Nosebleeds. | It has been so much better and easier than any other chemo that I have taken. Definitely recommend it. | F | 55 | 4 years 30 MG 1X M | 12/11/2021 | 4 | Metastatic breast cancer | Tired 3 to 4 days after | F | 66 | 2 days Drip 1X M | 4/18/2021 | 4 | HER2+ Breast Cancer Maint Drug | Very tired the next 4-5 days after treatment | F | 37 | 16 times 1X M | 11/30/2020 | 4 | Metastatic breast cancer | Tired nausea muscle pain | Looking to see if anyone has symptoms months after taking | F | 50 | 1 years 1X day | 10/17/2020 | 5 | Breast cancer | Nausea the following day after administration | F | 36 | 1 years | 1/21/2015 |
KADCYLA (ADO-TRASTUZUMAB EMTANSINE): Ado-trastuzumab emtansine is used alone to treat certain types of breast cancer. This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein. This medication is called a monoclonal antibody and microtubule inhibitor conjugate. Ado-trastuzumab emtansine works by attaching to the HER2 cancer cells and blocking them from dividing and growing. It may also destroy the cancer cells or signal the body (immune system) to destroy the cancer cells. (Sources: U.S. Centers for Medicare Services, FDA)